Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11219624 Topical formulation for a JAK inhibitor

Patent 11219624 was granted and assigned to Incyte on January, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071439 Process and intermediates for preparing a JAK inhibitor
0
Edits on 6 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11999751 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11905292 Process and intermediates for preparing a JAK inhibitor
0
Edits on 13 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Article (+288 characters)
Article

Patent abstract

This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1121962400
Edits on 28 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112196240
Date of Patent
January 11, 2022
0
Patent Application Number
169484080
Date Filed
September 17, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112196240
Patent Citations Received
‌
US Patent 11590138 Topical treatment of vitiligo by a jak inhibitor
0
‌
US Patent 11602536 Topical treatment of vitiligo by a JAK inhibitor
0
Patent Primary Examiner
‌
Dennis Heyer
0
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 15 Mar, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11602536 Topical treatment of vitiligo by a JAK inhibitor
0
Edits on 1 Mar, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11590138 Topical treatment of vitiligo by a jak inhibitor
0
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112196240
Date of Patent
January 11, 2022
0
Patent Application Number
169484080
Date Filed
September 17, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112196240
Patent Primary Examiner
‌
Dennis Heyer
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11219624
Edits on 13 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 13 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 11219624 Topical formulation for a JAK inhibitor

Infobox
Is a
Patent
Patent
Current assignee
Incyte
Incyte
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11219624
Date of patent
January 11, 2022
Patent application number
16948408
Date Filed
September 17, 2020
Patent primary examiner
‌
Dennis Heyer

Find more entities like US Patent 11219624 Topical formulation for a JAK inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo